|31.02||-0.64 / -2.02%|
Data as of 3:59pm ET
|31.02||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 41.50, with a high estimate of 60.00 and a low estimate of 37.00. The median estimate represents a +33.78% increase from the last price of 31.02.
The current consensus among 6 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.